These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26066761)

  • 1. Effects of Curcuma extract and visible light on adults with plaque psoriasis.
    Carrion-Gutierrez M; Ramirez-Bosca A; Navarro-Lopez V; Martinez-Andres A; Asín-Llorca M; Bernd A; Horga de la Parte JF
    Eur J Dermatol; 2015; 25(3):240-6. PubMed ID: 26066761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency and safety of a Curcuma extract combined with visible blue light phototherapy on adults with plaque psoriasis: A phase IV, randomized, open pilot clinical trial.
    Ramírez-Boscá A; Navarro-López V; Carrión-Gutiérrez M; Martínez-Andrés A; Vilata-Corell JJ; Asín-Llorca M; Horga de la Calle JF; Bernd A
    J Dermatol; 2017 Oct; 44(10):1177-1178. PubMed ID: 27790785
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
    Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
    Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis.
    Bagel J
    J Drugs Dermatol; 2011 Apr; 10(4):366-71. PubMed ID: 21455546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
    Bachelez H; van de Kerkhof PC; Strohal R; Kubanov A; Valenzuela F; Lee JH; Yakusevich V; Chimenti S; Papacharalambous J; Proulx J; Gupta P; Tan H; Tawadrous M; Valdez H; Wolk R;
    Lancet; 2015 Aug; 386(9993):552-61. PubMed ID: 26051365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.
    Lui H; Gulliver W; Tan J; Hong CH; Hull P; Shear NH; Paradiso-Hardy F; Bissonette R
    J Drugs Dermatol; 2012 Aug; 11(8):929-37. PubMed ID: 22859237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
    Ortonne JP; Khemis A; Koo JY; Choi J
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
    Spuls PI; Hooft L
    Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
    Asawanonda P; Nateetongrungsak Y
    J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, 'head-to-head' pilot study comparing the effects of etanercept monotherapy vs. etanercept and narrowband ultraviolet B (NB-UVB) phototherapy in obese psoriasis patients.
    Park KK; Wu JJ; Koo J
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):899-906. PubMed ID: 22702846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
    Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR;
    J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis.
    Brockow T; Schiener R; Franke A; Resch KL; Peter RU
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1027-37. PubMed ID: 17714121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol.
    Wollina U; Koch A; Scheibe A; Seme B; Streit I; Schmidt WD
    Skin Res Technol; 2012 May; 18(2):212-8. PubMed ID: 22092772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST).
    Weisenseel P; Reich K; Griemberg W; Merten K; Gröschel C; Gomez NN; Taipale K; Bräu B; Zschocke I
    J Dtsch Dermatol Ges; 2017 Feb; 15(2):180-186. PubMed ID: 28214304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
    Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
    van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
    Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
    Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
    J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H
    Front Immunol; 2022; 13():896476. PubMed ID: 35979355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension.
    Reich K; Ortonne JP; Gottlieb AB; Terpstra IJ; Coteur G; Tasset C; Mease P
    Br J Dermatol; 2012 Jul; 167(1):180-90. PubMed ID: 22413944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with etanercept 50 mg once weekly and narrow-band ultraviolet B phototherapy in chronic plaque psoriasis.
    De Simone C; D'Agostino M; Capizzi R; Capponi A; Venier A; Caldarola G
    Eur J Dermatol; 2011; 21(4):568-72. PubMed ID: 21697032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.